# Rheopheresis as Adjuvant Treatment of Calciphylaxis

> **NCT04654000** · NA · RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 138 (estimated)

## Conditions studied

- Metabolic Disorder
- End Stage Renal Disease
- Rare Diseases

## Interventions

- **PROCEDURE:** Rheopheresis procedure
- **PROCEDURE:** Sham-apheresis

## Key facts

- **NCT ID:** NCT04654000
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-07
- **Primary completion:** 2027-04
- **Final completion:** 2027-05
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04654000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04654000, "Rheopheresis as Adjuvant Treatment of Calciphylaxis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04654000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*